Bioactivity | Seclazone, a heterocyclic compound, possesses anti-inflammatory, analgesic, antipyretic and diuretic properties. Seclazone is orally active[1]. | ||||||||||||
In Vivo | Seclazone (220 mg/kg; p.o.; dietary, daily) inhibits the development of adjuvant-induced polyarthritis in rats[1].Seclazone significantly lowers the fever induced in rats by administration of a yeast suspension[1]. Animal Model: | ||||||||||||
Name | Seclazone | ||||||||||||
CAS | 29050-11-1 | ||||||||||||
Formula | C10H8ClNO3 | ||||||||||||
Molar Mass | 225.63 | ||||||||||||
Appearance | Solid | ||||||||||||
Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
Storage |
|
||||||||||||
Reference | [1]. F M Berger, et al. The pharmacological properties of seclazone (7-chloro-3,3a-dihydro-2H, 9H-isoxazolo (3,2-b) (1,3) benzoxazin-9-one) a new anti-inflammatory agent. Pharmacology. 1973;9(3):164-76. |